1. Effects of nutrients and serotonin 5-HT3 antagonism on symptoms evoked by distal gastric distension in humans
- Author
-
William L. Hasler, Chung Owyang, Morton B. Brown, Wenqin Pan, and Uri Ladabaum
- Subjects
Adult ,Male ,medicine.medical_specialty ,Duodenum ,Physiology ,Carbohydrates ,Pain ,Catheterization ,Granisetron ,Bloating ,Double-Blind Method ,Physiology (medical) ,Internal medicine ,Pressure ,medicine ,Humans ,Nutritional Physiological Phenomena ,Intubation, Gastrointestinal ,Hepatology ,business.industry ,Stomach ,Gastric distension ,digestive, oral, and skin physiology ,Gastroenterology ,Proteins ,Nausea ,Middle Aged ,Abdominal distension ,Lipids ,Barostat ,medicine.anatomical_structure ,Endocrinology ,Receptors, Serotonin ,Abdomen ,Female ,Serotonin Antagonists ,Serotonin ,Receptors, Serotonin, 5-HT3 ,medicine.symptom ,business - Abstract
Distal gastric distension may contribute to meal-related dyspeptic symptoms. This study's aims were to determine the effects of distinct nutrient classes on symptoms induced by distal gastric distension and their dependence on 5-hydroxytryptamine3 (5-HT3) receptors. Nine healthy subjects rated pain, nausea, and bloating induced by isobaric distal gastric distensions (6–24 mmHg) during duodenal lipid, carbohydrate, protein, or saline perfusion after treatment with placebo or the 5-HT3 receptor antagonist granisetron (10 μg/kg iv). Distensions produced greater pain, nausea, and bloating with lipid at 1.5 kcal/min compared with saline ( P≤ 0.02), primarily because of greater distal gastric volumes at each distending pressure. In contrast, carbohydrate and protein had no significant effect. At 3 kcal/min, lipid increased symptoms through a volume-independent as well as a volume-dependent effect. Granisetron did not affect symptom perception or gastric pressure-volume relationships. In conclusion, isobaric distal gastric distension produces more intense symptoms during duodenal lipid compared with saline perfusion. Symptom perception during distal gastric distension is unaffected by 5-HT3 receptor antagonism.
- Published
- 2001
- Full Text
- View/download PDF